HEART FAILURE NYHA CLASS II
Clinical trials for HEART FAILURE NYHA CLASS II explained in plain language.
Never miss a new study
Get alerted when new HEART FAILURE NYHA CLASS II trials appear
Sign up with your email to follow new studies for HEART FAILURE NYHA CLASS II, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Smart algorithm aims to improve heart failure care
Disease control CompletedThis study tested a new way to manage heart failure using a small heart monitor (Reveal LINQ) and a special algorithm. The goal was to see if this approach could safely guide treatment and improve outcomes for people with moderate heart failure. 826 participants with NYHA class I…
Matched conditions: HEART FAILURE NYHA CLASS II
Phase: NA • Sponsor: Medtronic Cardiac Rhythm and Heart Failure • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Could a Two-Drug combo ease heart failure and lung pressure?
Disease control CompletedThis completed study tested whether adding sildenafil to dapagliflozin helps heart failure patients who also have high blood pressure in their lungs. 100 participants received either dapagliflozin alone or both drugs. Researchers measured changes in heart pumping strength and lun…
Matched conditions: HEART FAILURE NYHA CLASS II
Phase: NA • Sponsor: Fayoum University • Aim: Disease control
Last updated Jun 26, 2026 13:04 UTC
-
Heart MRI breakthrough: new scan could replace needle biopsy for rare heart disease
Diagnosis CompletedThis study tested whether a special type of heart MRI, called T1 mapping, can accurately diagnose cardiac amyloidosis—a condition where abnormal proteins build up in the heart muscle. Researchers studied 112 older adults with heart failure and thickened heart walls. They compared…
Matched conditions: HEART FAILURE NYHA CLASS II
Sponsor: University of Leipzig • Aim: Diagnosis
Last updated Jun 27, 2026 12:06 UTC
-
Pacemaker tweak may ease heart failure by calming nerves
Symptom relief CompletedThis study tested a modified pacemaker in 34 people with heart failure (NYHA class II or III). The device delivers special pacing signals to reduce overactive sympathetic nerve activity, which can strain the heart. Researchers measured changes in arterial elastance, a sign of rel…
Matched conditions: HEART FAILURE NYHA CLASS II
Sponsor: BackBeat Medical Inc • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC